Pfizer (HAM:PFE) Inventories, Work In Process: €4,942 Mil (As of Mar. 2026)


HAM:PFE Pfizer Inc HAM:PFE
74 GF Score
Price €21.83
GF Value €23.01
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Inventories, Work In Process?

Pfizer HAM:PFE -0.27% 74 Inventories, Work In Process is €4,942 Mil as of Mar. 2026. GuruFocus rates HAM:PFE with a GF Score™ of 74/100 and a GF Value™ of €23.01 (Fairly Valued). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Pfizer's work in process for the quarter that ended in Mar. 2026 was €4,942 Mil.

Pfizer Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Pfizer's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Inventories, Work In Process Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,915.24 5,209.94 5,215.90 5,826.46 4,811.44

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,136.53 5,647.64 5,144.38 4,811.44 4,941.75
HAM:PFE
74GF Score
Pfizer Inc HAM:PFE
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €4,942 Mil mean?
Pfizer (HAM:PFE) has a Inventories, Work In Process of €4,942 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Pfizer and its competitors.
Is Pfizer's Inventories, Work In Process too high?
Pfizer's current Inventories, Work In Process is €4,942 Mil. Overall, Pfizer has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Inventories, Work In Process compare to GILD and BMY?
Pfizer's Inventories, Work In Process of €4,942 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Pfizer and its competitors. Pfizer's current Inventories, Work In Process is €4,942 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (HAM:PFE) is currently considered Fairly Valued. The stock's GF Value™ is €23.01, compared to a current price of €21.83 — trading 5.1% below its estimated fair value. The current Inventories, Work In Process is €4,942 Mil. Pfizer's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Pfizer (HAM:PFE), the current Inventories, Work In Process is €4,942 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (HAM:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of €21.83 is trading 5.1% below its estimated GF Value™ of €23.01. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for HAM:PFE:

  • Inventories, Work In Process: €4,942 Mil
  • GF Value™: €23.01 vs. price of €21.83 (5.1% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the HAM:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
74GF Score

Get the complete analysis for HAM:PFE

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.83
Price
€23.01
GF Value